1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5.
Global Recombinant
Protein Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Product (Hormone, Growth Factor, Antibody, Enzyme,
Other)
5.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
5.2.3. By
Region (North America, Europe, Asia Pacific, South America, Middle East &
Africa)
5.2.4. By
Company (2022)
5.3. Market Map
5.3.1
By Product
5.3.2 By Application
5.3.3 By Region
6.
North America
Recombinant Protein Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1. By
Product (Hormone, Growth Factor, Antibody, Enzyme, Other)
6.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
6.2.3.
By Country
6.3. North America: Country Analysis
6.3.1.
United States
Recombinant Protein Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Application
6.3.2.
Canada Recombinant
Protein Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Application
6.3.3.
Mexico Recombinant
Protein Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Application
7.
Europe Recombinant
Protein Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Product (Hormone, Growth Factor, Antibody, Enzyme,
Other)
7.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
7.2.3.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Recombinant
Protein Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Application
7.3.2.
Germany Recombinant
Protein Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Application
7.3.3.
United Kingdom
Recombinant Protein Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Application
7.3.4.
Italy Recombinant
Protein Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Application
7.3.5.
Spain Recombinant
Protein Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Application
8.
Asia-Pacific
Recombinant Protein Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Product (Hormone, Growth Factor, Antibody, Enzyme,
Other)
8.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
8.2.3.
By Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Recombinant
Protein Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Application
8.3.2.
India Recombinant
Protein Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Application
8.3.3.
Japan Recombinant
Protein Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Application
8.3.4.
South Korea
Recombinant Protein Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Application
8.3.5.
Australia Recombinant
Protein Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Application
9.
South America
Recombinant Protein Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Product (Hormone, Growth Factor, Antibody, Enzyme,
Other)
9.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
9.2.3.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Recombinant
Protein Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Application
9.3.2.
Argentina
Recombinant Protein Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Application
9.3.3.
Colombia Recombinant
Protein Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Application
10.
Middle East and
Africa Recombinant Protein Market Outlook
10.1.
Market Size &
Forecast
10.1.1.
By Value
10.2.
Market Share &
Forecast
10.2.1.
By Product (Hormone, Growth Factor, Antibody, Enzyme,
Other)
10.2.2.
By
Application (Research Application, Therapeutic Use, Biotechnology Industry)
10.2.3.
By Country
10.3.
MEA: Country
Analysis
10.3.1.
South Africa
Recombinant Protein Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Application
10.3.2.
Saudi Arabia
Recombinant Protein Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Application
10.3.3.
UAE Recombinant
Protein Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Application
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Global Recombinant Protein Market: SWOT Analysis
14.
Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15. Competitive Landscape
15.1.
Abbvie Inc.
15.1.1.
Business Overview
15.1.2.
Product Offerings
15.1.3.
Recent Developments
15.1.4.
Financials (As
Reported)
15.1.5.
Key Personnel
15.1.6.
SWOT Analysis
15.2.
Amgen Inc.
15.3.
Bio-Rad Laboratories
Inc.
15.4.
Eli Lilly and Company
15.5.
Merck KGaA
15.6.
Novo Nordisk AS
15.7.
Sanofi SA
15.8.
Thermo Fisher
Scientific Inc.
15.9.
Novartis AG
15.10.
GlaxoSmithKline PLC
15.11.
Novavax Inc.
15.12.
Pfizer Inc.
16. Strategic Recommendations